Deep brain stimulation (DBS) affects diverse neuronal populations through electrical modulation, fundamentally altering pathological network activity in movement disorders, psychiatric conditions, and emerging applications in neurodegenerative diseases. Understanding which neurons are affected and how DBS modulates their activity is critical for optimizing therapeutic outcomes in Parkinson's disease, essential tremor, dystonia, and other conditions.[1]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:1001579 | cerebral cortex glial cell |
The STN is the most common DBS target for PD:[2]
| Neuron Type | Neurotransmitter | DBS Effect | Clinical Outcome |
|---|---|---|---|
| Glutamatergic projection | VGLUT2 | Rate suppression/regularization | Reduced bradykinesia, rigidity |
| GABAergic interneuron | GABA | Activation → inhibition | Local network modulation |
| Parvalbumin+ | GABA | Fast-spiking modulation | Oscillation reduction |
STN Neuron Physiology:
GPi DBS affects basal ganglia output neurons:[3]
| Neuron Type | Neurotransmitter | DBS Effect | Clinical Outcome |
|---|---|---|---|
| GABAergic projection | GABA | Rate modulation | Dyskinesia reduction |
| Cholinergic interneuron | ACh | Modulated activity | Motor/nonmotor effects |
| PV+ fast-spiking | GABA | Pattern normalization | Tremor reduction |
GPi Neuron Characteristics:
Vim DBS primarily affects thalamocortical relay neurons:[4]
| Neuron Type | Neurotransmitter | DBS Effect | Clinical Outcome |
|---|---|---|---|
| Relay neurons | VGLUT2 | Firing modulation | Tremor suppression |
| GABAergic interneurons | GABA | Inhibition modulation | Network stabilization |
| Nucleus reticularis | GABA | Thalamocortical gating | Rhythm disruption |
Vim Neuron Properties:
DBS affects neurons through multiple mechanisms:[5]
Direct Effects:
Network Effects:
Plasticity Effects:
Excessive beta oscillations in PD networks are normalized by DBS:[6]
DBS affects neurotransmitter systems:[7]
| Neurotransmitter | Source | DBS Effect | Implication |
|---|---|---|---|
| Dopamine | Striatal terminals | Enhanced release | Motor benefit |
| GABA | GPi/SNr output | Pattern normalization | Reduced inhibition |
| Glutamate | STN output | Rate reduction | Cortex normalization |
| Acetylcholine | PPN/Striatum | Modulation | Non-motor effects |
STN DBS affects cortical neurons via:[8]
Vim DBS affects cerebellar circuitry:[9]
PPN DBS targets cholinergic neurons:[10]
| Neuron Type | Neurotransmitter | Percentage | DBS Effect |
|---|---|---|---|
| Cholinergic | ACh | ~25% | Arousal/gait improvement |
| Glutamatergic | VGLUT2 | ~50% | Locomotor activation |
| GABAergic | GAD67 | ~25% | Local inhibition |
PPN Clinical Effects:
PD DBS affects pathologically altered neurons:[11]
Dopaminergic Denervation Effects:
Alpha-Synuclein Pathology:
Motor Circuit Changes:
Dystonia DBS affects motor learning circuits:[12]
ET DBS affects tremor-generating circuits:[13]
Experimental DBS for AD targets:[14]
Affected Neurons:
HD DBS targets:[15]
| Marker | Neuron Type | Function | DBS Response |
|---|---|---|---|
| VGLUT2 | Glutamatergic | Vesicular glutamate | Rate modulation |
| GAD67 | GABAergic | GABA synthesis | Pattern change |
| PV | Fast-spiking | Calcium buffering | Oscillation reduction |
| ChAT | Cholinergic | ACh synthesis | PPN modulation |
| c-Fos | Activity marker | IEG activation | Activity mapping |
Precise targeting affects which neurons are stimulated:[16]
Stimulation parameters affect neuronal responses:[17]
| Parameter | Range | Neuronal Effect |
|---|---|---|
| Frequency | 130-185 Hz | Oscillation disruption |
| Amplitude | 1-4 V | Axon recruitment radius |
| Pulse width | 60-120 μs | Fiber type selectivity |
Adverse effects from stimulation of non-target neurons:[18]
Adaptive stimulation based on neural activity:[19]
Emerging DBS applications:[20]
Nucleus basalis for AD
Locus coeruleus for attention
Ventral tegmental area for motivation
Lateral hypothalamus for metabolic effects
Parkinson's disease essential tremor
Glutamatergic Neurons
Thalamocortical Relay Neurons
Hippocampal CA1 neurons
Lozano AM, Lipsman N. [Probing and regulating focal neural circuits with deep brain stimulation](https://doi.org/10.1016/S1474-4422(13). Lancet Neurol. 2013. ↩︎
Hammond C, Bergman H, Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci. 2007. ↩︎
Anderson TR, et al. Selective vulnerability of subthalamic nucleus neurons to low-frequency stimulation. J Neurophysiol. 2018. ↩︎
Hua SE, Lenz FA. Posture-related oscillations in human thalamus and subthalamic nucleus. J Neurosci. 2005. ↩︎
McIntyre CC, Hahn PJ. Network perspectives on the mechanisms of deep brain stimulation. Neurobiol Dis. 2010. ↩︎
Eusebio A, Brown P. Synchronisation in the beta frequency-band—the bad boy of parkinsonism or an innocent bystander? Exp Neurol. Exp Neurol. 2009. ↩︎
Creed M, et al. Addiction therapy: Refining deep brain stimulation to emulate extinction of drug-seeking circuitry. Neuron. 2015. ↩︎
Li Q, et al. Therapeutic deep brain stimulation in Parkinsonian rats directly influences motor cortex. Neuron. 2012. ↩︎
Deuschl G, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006. ↩︎
Ferraye MU, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain. 2010. ↩︎
Gradinaru V, et al. Optogenetic stimulation of dorsal raphe serotonergic neurons for treatment of depression-related behaviors. Biol Psychiatry. 2016. ↩︎
Ostrem JL, Starr PA. Treatment of dystonia with deep brain stimulation. Neurotherapeutics. 2008. ↩︎
Benabid AL, et al. Combined (thalamotomy and STN) deep brain stimulation for the treatment of Parkinson's disease and tremor disorders. Acta Neurochir Suppl. 2007. ↩︎
Laxton AW, et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol. 2010. ↩︎
Moro E, et al. Long-term results of bilateral globus pallidus stimulation for Huntington's disease. J Neurol. 2017. ↩︎
Zaidel A, et al. Subthalamic span of β oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease. Brain. 2010. ↩︎
Rizzone M, et al. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: effects of variation of stimulation parameters. J Neurol Neurosurg Psychiatry. 2001. ↩︎
Witt K, et al. [Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study](https://doi.org/10.1016/S1474-4422(08). Lancet Neurol. 2008. ↩︎
Tinkhauser G, et al. Beta burst dynamics in Parkinson's disease OFF and ON dopaminergic medication. Brain. 2017. ↩︎
Lüscher C, et al. Deep brain stimulation: From neurology to psychiatry. Nat Rev Neurol. 2023. ↩︎